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Objective: The presence of a high ankle-brachial index (ABI) is related to stiff ankle arteries due to medial calcification.
Recently, this condition has attracted new interest after reports of a worse cardiovascular prognosis, similar to a low ABI.
We sought to compare risk factors contributing to a low (<0.90) and high (>1.40) ABI. Additionally, we hypothesized
that in instances of high ABI, occlusive PAD may coexist.
Method: This cross-sectional study was conducted at vascular laboratories in a university medical center. The subjects were 510
ambulatory patients (37% had diabetes) previously examined at our vascular laboratories and who responded positively to our
invitation. We collected data on smoking, diabetes, hypertension, dyslipidemia, and cardiovascular disease history. The
noninvasive assessment of lower limb arteries consisted of the measurement of ABI, toe-brachial index (TBI), and posterior
tibial artery peak flow velocity (Pk-PT). A TBI >0.7 and a Pk-PT >10 cm/s were considered normal.
Results:High- and low-ABI were detected, respectively, in 2.1% and 57.8% of limbs. For a low ABI, age (odds ratio [OR],
1.29/10 y), pack-years (OR, 1.08/10 units), and hypertension (OR, 1.90) were independent significant (P < .001)
factors. A strong association was found between diabetes and high ABI (OR, 16.0; P < .001). When ABI ranges were
compared with TBI and Pk-PT results, those with ABI<0.90 and ABI>1.40 presented similar patterns of abnormalities.
Pk-PT or TBI, or both, was abnormal in more than 80% of cases in both ABI <0.90 and >1.40 groups. The ABI vs TBI
relationship appeared linear in nondiabetic patients, but had an inverted J-shape in diabetic patients, suggesting high ABI
masked leg ischemia.
Conclusions: Diabetes is the dominant risk factor for a high (>1.40) ABI. Occlusive PAD is highly prevalent in subjects
with high ABI, and these subjects should be considered as PAD-equivalent. ( J Vasc Surg 2008;48:1197-203.)The measurement of ankle-brachial index (ABI) is
widely used for the diagnosis of peripheral arterial disease
(PAD) as well as the estimation of its severity and progres-
sion. There is extensive evidence that both symptomatic
and asymptomatic PAD are predictive for further cardiovas-
cular disease (CVD) events.1-3 Routine use of ABI in
higher-risk subjects has been proposed in primary care.1,2
In some infrequent cases, the measurement of ankle
pressures is impeded by stiff or incompressible arteries, even
with pressures as high as 300 mm Hg. This leads either to
the inability to obtain the ABI or to very high values. This
situation has been reported to be more frequent in patients
with diabetes mellitus (DM)4-7 and in those with end-stage
renal disease.4,8 Arterial stiffening is attributed to calcifica-
tions in the arterial wall. This occurs with medial artery
calcinosis (MAC), corresponding to a high accumulation of
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doi:10.1016/j.jvs.2008.06.005calcium in the medial layer, without any protruding lesion
in the arterial lumen.9 Because the arterial stiffness to cuff
pressure precludes an accurate blood pressure measure-
ment, several PAD epidemiologic studies have excluded
patients with high or indeterminable ABI.10,11 This has
recently received new attention, because it has been re-
ported that a high ABI is correlated with subclinical
CVD12,13 and is associated with higher rates of total and
cardiovascular mortality, both in general14,15 and coronary
populations.16
Nevertheless, risk factors for this condition are not
clearly understood. Furthermore, because ABI cannot di-
agnose PAD in the presence of stiff arteries, the relationship
between high ABI and concomitant PAD is unknown.
Our first aim in this study was to compare the risk
factors associated with a high ABI, as a marker of MAC,
with those related to a low ABI, as a marker of occlusive
PAD. We hypothesized that risk factors or their levels of
association, or both, would differ in these two conditions.
In addition, we hypothesized that a substantial fraction of
limbs with a high ABI would have occlusive arterial disease
when assessed by other noninvasive means. Because high
rates of elevated ABI are reported among patients with
DM, we also conducted analyses stratified by DM status.
METHODS
Study population. From 1990 to 1994, we studied
510 patients invited to visit our vascular laboratory for a
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the lower limbs. They were recruited from a pool of 2265
people who visited either the San Diego Veterans Admin-
istration Center or the University of California, San Diego
Medical Center vascular laboratories between 1980 and
1990. The study population consisted of survivors who
were located and willing to participate. The major goal of
the original study was to investigate the natural history of
PAD.17,18 Data assessment, including patient’s interview,
physical examination, fasting blood sample analyses, and
noninvasive vascular testing has been described in detail
elsewhere.17,19
All participants gave their informed written consent for
their participation in the studies and the use of their data for
future research. The study protocol and consent form were
approved by the University of California, San Diego Inves-
tigational Review Board.
Data definition. Ethnicity was self-reported. The
number of cigarette pack-years defined smoking history.
Hypertension was defined in patients taking an antihyper-
tensive medication or with a resting arm systolic blood
pressure 140 or diastolic blood pressure 90 mmHg.
Participants reporting any use of lipid-lowering drugs or a
total cholesterol to high-density lipoprotein cholesterol
ratio 5 were categorized as dyslipidemic.
DM status was defined either as a self-reported DM
diagnosis or taking anti-DM drugs. In additionally, those
without any report of DMbut with a fasting plasma glucose
126 mg/dL at the study visit were classified as new DM
patients. DM patients aware of their condition answered
questions about their use of insulin and oral medications
and the date of DM onset. The length of DM diagnosis was
calculated by subtracting the age of DM onset from the
participant’s age at the study visit. Body mass index (BMI)
was calculated from values for weight and height as kg/m2.
Noninvasive vascular tests. The ankle-brachial index
(ABI) and the toe-brachial index (TBI) were obtained after
blood pressure measurement at arms, ankles, and great toes
by the sphygmomanometric technique. The signals were
detected by photoplethysmography at the third finger for
the arm and great toe for both indexes. Because of the
known association between subclavian stenosis and PAD,20
the higher brachial systolic pressure was used for the ABI and
TBI denominators. Peak flow velocities of the posterior tibial
artery (Pk-PT) were measured by Doppler ultrasound imag-
ing using the maximum amplitude search technique.21
Normal ABI values were considered between 0.91 and
1.39, and a TBI 0.70 and Pk-PT 10 cm/s were also
considered normal.17,21,22 These criteria have been vali-
dated against angiographically documented occlusion
50%.21,22 A significant obstructive (50% stenosis) le-
sion in large vessels, from the iliac to the ankle arteries,
would affect ABI results, except when the presence ofMAC
precluded actual ABI results. A low ABI or low Pk-PT, or
both, as defined in this study, present 89% sensitivity and
99% specificity to detect PAD in those large vessels.22 In
addition, low TBI reflects the presence of any flow obstruc-
tion in leg arteries, down to the toe arteries. Because thepresence of MAC at the base of the great toe is infre-
quent,23 the probability of an inadequate TBI value similar
to what is reported for ABI is low. Data regarding the
reproducibility of these variables are reported elsewhere.17
Statistical methods. Except for the study population
description, we performed a limb-specific analysis. The
demographic and clinical characteristics were assessed,
stratified by three different ABI ranges (1) low: ABI0.90,
(2) intermediate: ABI between 0.91 and 1.39, and (3) high:
ABI1.40. For the assessment of risk factors, we also classi-
fied all revascularized limbs in the low ABI group, except
for those with ABI1.40, which have been classified in the
high ABI group. These three ABI ranges were the depen-
dent variables used to answer the first hypothesis, all other
covariates served as the independent variables.
Logistic regression analysis was used to obtain odds
ratios with 95% confidence intervals (95% CI) for all vari-
ables at two ABI ranges: low ABI (0.90) and high ABI
(1.40). The reference ABI range for these two models
was between 0.91 and 1.39.
To assess which risk factors were predictive of a given
ABI range, two sets of fully adjusted logistic regression
models were used. The dependent variables were low vs
intermediate ABI in the first model, and high vs interme-
diate ABI in the second model. All models contained CVD
risk factors except gender, because we did not observe any
women with stiff arteries.
The possibility of confounding was eliminated by look-
ing at the effect on point estimates by selectively removing
covariates from the model one at a time. Because of the
possible correlation between observations within an indi-
vidual, the same analyses were repeated with application of
generalized estimated equations (GEE) methods.24 Sepa-
rate logistic regression GEE models were fit comparing
ABI categories low (ABI 0.90) vs intermediate and high
(ABI 1.40) vs intermediate ABI. Because the GEE mod-
els compared either high or low ABI vs intermediate ABI,
five individuals with ABI 0.9 on one limb and ABI 1.4
on the other limb were excluded from the GEE analysis.
To assess the actual lower limb perfusion of legs with
raised ABI, limbs in the three ABI ranges were studied for
lower limb perfusion by looking at the limb’s TBI and
Pk-PT velocity. In this case we used actual ABI values,
without considering whether the limbs were previously
revascularized or not. We plotted TBI values by the corre-
sponding ABI values and stratified limbs by DM status. We
looked for different lower limb vascular patterns by fitting
the data points to linear and quadratic lines. Again, due to
possibly correlated values within individuals, a mixed-
effects model24 was used with outcome of the repeated
TBI scores. ABI scores were the fixed-effects predictor. A
random intercept term was included to account for be-
tween-subject variability. Likelihood ratio tests were used
to compare the linear model with the quadratic model.
Akaike information criteria values were also obtained for
each model.
The study used the statistical software SAS 8.0 (SAS
Inc, Cary, NC), R 2.2.1 (R Foundation for Statistical
JOURNAL OF VASCULAR SURGERY
Volume 48, Number 5 Aboyans et al 1199Computing, Vienna, Austria), and Minitab 13.1 (Minitab
Inc, State College, Pa) for data analysis.
RESULTS
Among the 2265 potential candidates, 481 had died,
1276 could not be located or declined the invitation, and 508
patients returned for a new, comprehensive, noninvasive vas-
cular examination of the lower limbs as well as an assessment
of their CVD risk factors with a standard questionnaire, and
undergoing a clinical examination and providing a fasting
blood sample for further analyses. Data for these 508 patients
have been compared with those abstracted at baseline in 77
survivors randomly selected among those who declined the
invitation or who were not located.17 The participants had
slightly less advanced PAD according to noninvasive tests, but
were otherwise comparable.
The study population consisted of 448 men and 62
women. Most were non-Hispanic whites. Demographic
and clinical data are reported in Table I. In addition to the
158 patients with known DM, 31 new cases were diag-
nosed during the study visit.
Among the 1020 limbs, six were excluded for absent
ABI data due to amputations. Among the 1014 limbs
available, 586 (57.8%) had an ABI 0.90 and 21 (2.1%)
had an ABI 1.40. Demographic data and risk factors
according to the three ABI ranges are summarized in
Table II. Notably, 19 of the 21 legs (91%) with an ABI
1.40 belonged to DM patients. These 21 legs corre-
Table I. Demographic and clinical characteristics of
study participant
Variable No. (%) or mean (range)
Patients, total 510
Males 448 (87.8)
Age, years 68.0 (30-100)
Ethnicity
Non-Hispanic white 445 (87.3)
Hispanic 28 (5.5)
African American 23 (4.5)
Native American 10 (2.0)
Other 4 (0.9)
Peripheral arterial diseasea 382 (74.9)
Previous limbs revascularization 178 (34.9)
Body mass index, kg/m2 27.0 (17-51)
Pack-years smoked 48.6 (0-270)
DMb 189 (37.1)
Hypertension 404 (79.2)
Dyslipidemia 270 (52.9)
DM patients, No.c 158
Treatment variables
Insulin (ever) 106 (67.1)
Oral medication (ever) 131 (82.9)
Length of diagnosis,c years 16.1 (0-62)
DM, Diabetes mellitus.
aDefined by ankle-brachial index 0.90 or peak tibial flow 10 cm/s.
bDefined as self-report, previous diagnosis, or fasting plasma glucose 126
mg/dL.
cOnly in those with known diabetes.sponded to 14 patients, including 12 with DM.Table III reports the logistic regression models, look-
ing for independent risk factors for low ABI (0.90) and
high-ABI (1.40). Age, pack-years of smoking, and hyper-
tension were the significant predictors of a low ABI, with
borderline results for DM patients. For a high ABI, the
odds ratio of DM was 15.97 (95% CI, 3.2-66.1). BMI
presented near to significant results as a risk factor for high
ABI. The model revealed dyslipidemia as a significant pro-
tective factor for stiff arteries. The results using GEE mod-
els were similar (data not presented). Notably, we redid the
same analyses, keeping only patients’ limbs that were both
in the intermediate ABI range as the reference group; no
substantial differences were found compared with the re-
sults in Table III (data not shown). Regarding the potential
association of high ABI and occlusive disease, we stratified
patients according to the three ABI groups and the TBI and
Pk-PT results. Complete data were available for 959 limbs,
including Pk-PT and TBI. Fig 1 displays the limbs distri-
bution according to the combination of TBI and Pk-PT
results in the three ABI classes. The distribution of those
with a high ABI differed substantially from those with a
normal ABI and was similar to the proportions obtained in
limbs with PAD. In the high ABI group, 18 limbs (85.7%)
presented either a TBI 0.7 or a Pk-PT 10 cm/s, or
both, which is very similar to the 87.7% of cases with a low
ABI, and both were much higher than the 37.6% of cases
observed in the intermediate ABI group.
Table IV summarizes the same distribution according
to the DM status. Because only two non-DM patients had
one limb with a high ABI, we could not statistically com-
pare their distribution with that of their low ABI counter-
parts. The distribution of flow abnormalities in diabetic
limbs, as assessed by TBI and Pk-PT, follows the same
pattern as results of limbs not stratified by DM status (Fig
1). Limbs in ABI ranges at either end of the spectrum had
a low TBI. In 84.2% of cases, diabetic limbs with ABI
1.40 had abnormal results in at least one of the two
noninvasive vascular indicators, suggestive of concomitant
occlusive disease.
We plotted ABI against TBI results for the study pop-
ulation and found different results according to the DM
status (Figs 2 and 3). In the absence of arterial stiffness, it
was expected that the linear model would fit the best for
presenting the relationship between ABI and TBI. In
non-DM patients, the likelihood ratio test statistic compar-
ing the linear vs the quadratic models was 14.73 (P 
.0001). The Akaike information criteria for the linear and
quadratic models were 522.88 and 535.62, respec-
tively. For the DM group, the likelihood ratio test statistic
was 25.67 (P  .0001). The Akaike information criteria
were 186.27 and 209.93. Thus, in both groups, the
quadratic model fit the data better than the linear model,
but this was more marked in the DM group. The quadratic
model in the DM group (Fig 3) suggests an inverted
J-shape relationship. This nonlinear relationship,muchmore
pronounced in the DM group, demonstrates that arterial
stiffness affects the ABI-TBI relationship, slightly in non-DM
subjects (Fig 2), but dramatically in the DM patients (Fig 3).
mg/d
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This study confirmed our hypothesis that subjects with
a high ABI are differently associated with CVD risk factors
than those with a low ABI. DM appeared as the dominant
risk factor for a high ABI. Our study also suggests that high
ABI masks frequently occlusive PAD.
Described by Mönckeberg,9 MAC does not affect the
intima. Hence, luminal obstruction is not a consequence.
After autopsy studies,9,25 these lesions were well docu-
mented in the living using soft-tissue radiographs, with an
aspect likened to railroad tracks.26 This condition can also
be revealed by an excessive resistance to the cuff pressure.
Data on MAC epidemiology are sporadic. In a German
survey conducted on 4814 subjects aged 45 to 75 years, the
prevalence of ABI 1.30 and ABI 1.50 was reported at
13.3% and 1.1% in men and 6.9% and 0.5% in women,
respectively.27 In the Epidemiology of Diabetes Complica-
Table II. Demographic and clinical characteristics of limb
Variables 0.90
Patients, No. 586
Age, mean (range) years 68.9 (41-100
Males, No. (%) 525 (89.6)
Ethnicity, No. (%)
Non-Hispanic White 515 (87.9)
Hispanic 27 (4.6)
African American 28 (4.8)
Native American/Asian 15 (2.6)
Other 1 (0.2)
BMI, mean (range) kg/m2 27.1 (18-41)
Pack-years, mean (range) 53.4 (0-270)
Diabetes mellitusa 227 (38.7)
Hypertension 492 (84.0)
Dyslipidemia 317 (54.1)
aDefined as self-report, previous diagnosis, or fasting plasma glucose 126
Table III. Association of cardiovascular disease risk
factors with low and high ankle-brachial index according
to multiply adjusted logistic regression modelsa
Variables
ABI 0.90b ABI 1.40b
ORb P ORb P
Age (per 10 years) 1.29 .001 0.79 .356
Ethnicity
Non-Hispanic white 1.00 1.00
Other 1.04 .810 1.35 .635
Body mass index (per kg/m2) 1.00 .646 1.08 .102
Pack-years smoking (per 10
units) 1.08 .001 1.04 .377
Hypertension 1.90 .001 2.05 .372
Dyslipidemia 1.09 .550 .23 .011
History of diabetes mellitus 1.31 .067 15.97 .001
ABI, Ankle-brachial index; OR, odds ratio.
aReference range is 0.91 to 1.40.
bVs normal ABI range (0.91 to 1.40) as the reference group.tion study in young patients with type 1DM,DMduration,hypertension, and the triglycerides/apolipoprotein A1 ra-
tio were independent risk factors of MAC.6 The Cardiovas-
cular Health Study14 and the National Health and Nutri-
tion Examination Survey7 showed DM prevalence as high
as twice in those with an ABI1.40 compared with normal
groups. Several pathways are proposed to explain arterial
stiffening in DM patients. Insulin triggers cultured smooth
muscle cell proliferation.28 Hyperglycemia is responsible of
nonenzymatic glycosylation of several proteins, including
collagen and elastin.29 It has also been suggested thatMAC
is related to diabetic neuropathy.30-33
We found an inverse association between dyslipidemia
and high ABI. This has also been reported in the Cardio-
vascularHealth Study (CHS).14One explanation is that the
combination of high low-density lipoprotein and DM is
highly atherogenic.34 This would favor the development of
occlusive rather than stiffening disease, shifting some pa-
tients with mild MAC and occlusive disease to the interme-
diate ABI range.
Forty years ago, Ferrier26 revealed a positive association
between MAC and the narrowing and occlusion in ampu-
Fig 1. Proportions of limbs characterized by toe brachial index
(TBI) and peak tibial flow velocity (Pk-PT), stratified by ankle-
brachial index (ABI) ranges.
atified by ankle-brachial index categories
Ankle-brachial index
0.91 to 1.40 1.40
407 21
67.0 (30-100) 63.6 (39-84)
346 (85.0) 21 (100)
353 (86.7) 17 (81.0)
25 (6.1) 4 (19.0)
17 (4.2) 0 (0)
5 (1.2) 0 (0)
7 (1.7) 0 (0)
27.3 (17-52) 30.3 (21-42)
41.8 (0-165) 52.2 (0-225)
129 (31.7) 19 (90.5)
293 (71.0) 19 (90.5)
214 (52.6) 7 (33.3)
L.s, str
)tated foot arteries. In Native Americans with DM, radio-
d.
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for an ipsilateral amputation, suggestive of concomitant
occlusive disease.31 Using 133xenon, Christensen35 re-
ported a decreased muscular blood flow in DM patients
with MAC. Among 42 DM patients, angiographic occlu-
sive lesions were significantly more frequent in vessels with
radiographic MAC than those without MAC.32 Quigley et
al36 found that the relationship between ankle Doppler
pressure and skin perfusion pressure differed in patients
with and without DM. The authors concluded that even in
normal ABI ranges, the actual foot perfusion pressure
might be overestimated at some level in DM patients.
In a series of DM patients with foot ulcers,37 angiog-
raphy revealed50% stenosis in 16 of 17 cases, with an ABI
1. In another series of patients with chronic limb isch-
Table IV. Proportions of limbs characterized by toe-brach
ankle-brachial index levels and diabetes statusa
TBI and Pk-PT
ABI low, no.
Diabetes
Yes (n  200) No
TBI 0.70 and Pk-PT 10 cm/s (n  362) 20 (10.9)
TBI 0.70 and Pk-PT 10 cm/s (n  49) 1 (0.6)
TBI 0.70 and Pk-PT 10 cm/s (n  311) 78 (42.6) 1
TBI 0.70 and Pk-PT 10 cm/s (n  237) 84 (45.9) 1
TBI 0.70 or Pk-PT 10 cm/s (n  627) 174 (89.7) 2
Pk-PT, Peak tibial flow velocity; TBI, toe-brachial index.
aIn each cell, only limbs with the corresponding data available were include
Fig 2. Distribution of toe brachial indices (TBI) by ankle-bra-
chial indices (ABI) in nondiabetic patients as well as the linear
(blue slope) and quadratic relationships (purple curve) between
both indexes.emia, those with incompressible arteries had higher rates ofamputation.38 This underlines the pitfall of a normal ABI
reading in DM patients. In addition, the profunda femoral
artery is mostly affected in DM patients,39 but abnormali-
ties cannot be detected by ABI because it does not contrib-
ute to ankle perfusion, except when it supplies a pathologic
superficial femoral artery.
In a study combining a community-dwelling cohort
with two cohorts from vascular laboratories,40 the preva-
lence of any kind of leg pain decreased progressively from
the lowest ABI range up to the 1.20 to 1.29 range, and rose
again beyond this range. The rates of atypical pain and
classic claudication in the 1.40 group were similar to
those observed in the 0.90 to 0.99 group, suggesting that a
similar level of occlusive disease exists in these two ABI
ranges.
The parallel between radiologic MAC and high ABI
ndex and peak tibial flow velocity ranges, stratified by
ABI intermediate, no. (%)
Diabetes ABI high, no. (%)
279) Yes (n  150) No (n  353) Yes (n  19) No (n  2)
2.0) 92 (64.8) 215 (62.0) 3 (15.8) 0 (0)
.0) 4 (2.8) 24 (6.9) 3 (15.8) 1 (50)
1.4) 31 (21.8) 83 (23.9) 8 (42.1) 1 (50)
0.6) 15 (10.6) 25 (7.2) 5 (26.3) 0 (0)
8.5) 51 (35.7) 138 (39.1) 16 (84) 2 (100)
Fig 3. Distribution of toe brachial indexes (TBI) by ankle bra-
chial indexes (ABI) in diabetic patients as well as the linear (blue
slope) and quadratic relationships (purple curve) between both
indexes.ial i
(%)
(n 
32 (1
16 (6
10 (4
08 (4
46 (8should be made with caution. It is probable that x-rays
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reflect a more progressed disease.23,33 Therefore, the prin-
cipal contribution of our study here should be interpreted
in the light of recent findings on the prognostic value of a
high ABI.14-16Without reconsidering the prognostic infor-
mation provided by a high ABI, our findings suggest that
many—but not all—patients with high ABI actually have
associated PAD, and this might at least partially explain the
prognostic value of a high ABI.
Recently, Suominen et al41 published similar findings
in a population referred to a vascular surgery unit for PAD
diagnosis. Using a more liberal high ABI criterion (1.30),
they found a DM prevalence of 49%. According to their
criterion, 62.5% of the patients in our study with an ABI
1.30 in at least one limb hadDM. In patients with an ABI
1.30, they report a PAD prevalence of 62.2%, defined
only by a TBI of 0.60.41 Using the same 1.30 ABI
threshold, we found 54.2% of our patients with a TBI of
0.70. Thus, the findings in our study are concordant with
their report.
Our study presents some limitations. We studied nei-
ther the presence of peripheral neuropathy42 nor heredity,
both considered as independent risk factors of MAC.24,43
In addition, we did not assess the osteogenic process, which is
involved in median calcinosis formation in vascular smooth
muscle cells.4,44 Finally, subjects were usually referred to the
vascular laboratory for evaluation for PAD, and we cannot
expand our findings to the general population.
CONCLUSION
In this cross-sectional study, a low ABI was associated
with standard CVD risk factors, whereas a high ABI was
only associated with DM. Nonetheless, associations be-
tween low and high ABI levels and other measures of distal
perfusion were similar, indicating that a high ABI is fre-
quently associated with occlusive PAD. This confirms the
necessity for requiring other noninvasive tests in patients
with an ABI 1.40. Because these additive methods will
frequently diagnose underlying PAD, these patients should
be considered as PAD equivalents, not only from a general
prognostic point of view but also for the potential trophic
and functional consequences of lower limb malperfusion.
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